Mark Stenhouse

Direktor/Vorstandsmitglied bei PHATHOM PHARMACEUTICALS, INC.

Vermögen: 81 900 $ am 30.04.2024

57 Jahre

Health Technology

Consumer Services

Aktive Positionen von Mark Stenhouse

Unternehmen	Position	Beginn	Ende
PHATHOM PHARMACEUTICALS, INC.	Direktor/Vorstandsmitglied	17.03.2020	-
PHATHOM PHARMACEUTICALS, INC.	Independent Dir/Board Member	17.03.2020	-

Unternehmen	Position	Beginn	Ende
PROMETHEUS BIOSCIENCES, INC.	Geschäftsführer	04.03.2021	16.06.2023
EXACT SCIENCES CORPORATION	Corporate Officer/Principal	01.04.2018	01.01.2021
Prometheus Laboratories, Inc. Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA.	Direktor/Vorstandsmitglied	01.05.2018	01.10.2020
ABBVIE INC.	Corporate Officer/Principal	01.10.2016	01.03.2018
ABBOTT LABORATORIES	Corporate Officer/Principal	01.09.2006	01.03.2010

College of Charleston

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Director/Board Member	2
Independent Dir/Board Member	1

Sektoral

Health Technology	7
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	4
EXACT SCIENCES CORPORATION	Health Technology
PHATHOM PHARMACEUTICALS, INC.	Health Technology
ABBOTT LABORATORIES	Health Technology
ABBVIE INC.	Health Technology

Private Unternehmen	2
Prometheus Laboratories, Inc. Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA.	Health Technology
Prometheus Biosciences, Inc. Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA .	Health Technology

Private Unternehmen

Health Technology